JoHFR: A Multicenter Registry to Study the Characteristics and Outcomes of Jordanian Heart Failure Patients.

Sponsor
Jordan Cardio Vascular Research Group (Other)
Overall Status
Recruiting
CT.gov ID
NCT04829591
Collaborator
(none)
4,000
1
42
95.3

Study Details

Study Description

Brief Summary

Heart Failure research registry is a collection of computerized information about individuals with heart failure. The database in this registry is obtained from several Jordanian medical centers which will represent an extremely valuable resource for epidemiological research on heart failure patients.

Condition or Disease Intervention/Treatment Phase
  • Other: observational

Detailed Description

Understanding the cause of Heart Failure (HF) and how the body will respond to it, is critical for an effective treatment. HF is a global problem with significant morbidity and mortality, despite improved understanding of the pathophysiology and a growing range of therapeutic options. Jordanian Heart Failure Registry (JoHFR) will be the first research project of heart failure prevalence in Jordan. It is undertaken by primary healthcare professionals with main aim to improve knowledge about the care of patients with HF. The investigators responsible for conducting this research are physicians and their teams who deal with heart failure patients in their outpatient and inpatient clinic centers including the public and private medical sectors in Jordan's medical community. Standards in the Hashemite kingdom of Jordan complies with the recognized good guideline directed medical practices internationally

Study Design

Study Type:
Observational
Anticipated Enrollment :
4000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Jordanian Heart Failure Registry (JoHFR)
Actual Study Start Date :
Jul 1, 2021
Anticipated Primary Completion Date :
Dec 30, 2023
Anticipated Study Completion Date :
Dec 30, 2024

Outcome Measures

Primary Outcome Measures

  1. Cardiovascular death [12 months]

    The main objective of the JoHFR is to obtain reliable estimate of rates of cardiovascular death and or hospitalization for decompensated heart failure

Secondary Outcome Measures

  1. worsening kidney function [12 months]

    as compared to baseline eGFR

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients who are 18 years or older with Heart Failure diagnosis as defined by internationally recognized guidelines.

  2. Current residents of the Hashemite Kingdom of Jordan

Exclusion Criteria:
  1. Patients who refuse or unable to sign a consent form.

  2. Patient inability to follow up with provider

Contacts and Locations

Locations

Site City State Country Postal Code
1 Farah Medical Campus Amman Jordan 11180

Sponsors and Collaborators

  • Jordan Cardio Vascular Research Group

Investigators

  • Study Chair: Hadi M Abu-Hantash, MD,MSc, Interventional Cardiovascular Innovation group

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Hadi Abu-Hantash, principle investigator and study chair, University of Jordan
ClinicalTrials.gov Identifier:
NCT04829591
Other Study ID Numbers:
  • JoCVRG
First Posted:
Apr 2, 2021
Last Update Posted:
Apr 20, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 20, 2022